Cargando...

Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

Glioblastoma (glioblastoma multiforme; GBM; WHO Grade IV) accounts for the majority of primary malignant brain tumors in adults. Amplification and mutation of the epidermal growth factor receptor (EGFR) gene represent signature genetic abnormalities encountered in GBM. A range of potential therapies...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Taylor, Tiffany E., Furnari, Frank B., Cavenee, Webster K.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3464093/
https://ncbi.nlm.nih.gov/pubmed/22268382
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!